Nephros (NEPH) Interest & Investment Income (2010 - 2026)
Nephros (NEPH) posted quarterly Interest & Investment Income of $32000.0 for Q1 2026, up 146.15% year-over-year from $13000.0 in Q1 2025, and down 40.74% quarter-over-quarter from $54000.0 in Q4 2025.
Nephros (NEPH) Interest & Investment Income (2010 - 2026) Analysis & Trends
Nephros' Interest & Investment Income history runs 13 years deep, the most recent figure standing at $32000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 146.15% year-over-year to $32000.0; the TTM figure through Mar 2026 stood at $158000.0 (up 92.68% YoY), while the FY2025 annual figure was $139000.0, up 47.87% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $32000.0, down from $54000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $54000.0 in Q4 2025, with the low at $1000.0 in Q2 2022.
- The 5-year median for Interest & Investment Income is $20000.0 (2024), against an average of $20176.5.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income sank 66.67% in 2022, then surged 1200.0% in 2023.
- Nephros' Interest & Investment Income stood at $7000.0 in 2022, then jumped by 300.0% to $28000.0 in 2023, then changed by 0.0% to $28000.0 in 2024, then surged by 92.86% to $54000.0 in 2025, then plunged by 40.74% to $32000.0 in 2026.
- Business Quant data shows NEPH's Interest & Investment Income at $32000.0 in Q1 2026, $54000.0 in Q4 2025, and $41000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 4.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 20.89 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -119.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 3.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -64.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -64.00 Mn |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30,000.00 |
| Mar 31, 2026 | 32,000.00 |
| Dec 31, 2025 | 54,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Sep 30, 2023 | 11,000.00 |
| Jun 30, 2023 | 13,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 7,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |